The Council of Australian Therapeutic Advisory Groups (CATAG)
is an authoritative, expert, consensus-based collaboration of representatives from all Australian State and Territory Therapeutic Advisory Groups or their jurisdictional committee equivalents. CATAG aims to standardise and improve medicines use primarily (but not exclusively) in the hospital sector across Australia through:
For more information about CATAG including our strategic goals, member profiles, history and funding visit the about section.
Updates
Managing Medicines Access Programs : Guiding Principles for the governance of Medicines Access Programs in Australian hospitals. Version 2, June 2018
CATAG MAP Guiding Principles Version 2, 2018
Table 1 MAP cost recovery fee schedule 2018
CATAG forms for Medicine Access Programs
CATAG MAP pharmaceutical company acknowledgement form
CATAG MAP prescriber acknowledgement form
CATAG MAP patient consent form
Resources
Overseeing biosimilar use: Guiding Principles for the governance of biological and biosimilar medicines in Australian hospitals. Version 2, September 2016
Biosimilar use Version 2, Sept 2016. Download in Adobe PDF
Position Statement for the use of Complementary and Alternative Medicines, May 2015
Download in Adobe PDF format
Rethinking Medicines Decision Making : Guiding Principles for the quality use of off-label medicines
Brief Description
Download in Adobe PDF format
Achieving Effective Medicines Governance: Guiding Principles for the roles and responsibilities of Drug and Therapeutics Committees in Australian public hospitals
Brief Description
Download in Adobe PDF format
Appendix 6: Drug and Therapeutics Committees Checklist (version 1).
Download in Microsoft DOC format